BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35632981)

  • 1. Circulating tumor cells in neuroblastoma: Current status and future perspectives.
    Yang R; Zheng S; Dong R
    Cancer Med; 2023 Jan; 12(1):7-19. PubMed ID: 35632981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell next-generation sequencing of circulating tumor cells in patients with neuroblastoma.
    Kojima M; Harada T; Fukazawa T; Kurihara S; Touge R; Saeki I; Takahashi S; Hiyama E
    Cancer Sci; 2023 Apr; 114(4):1616-1624. PubMed ID: 36571449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review.
    Aktar S; Baghaie H; Islam F; Gopalan V; Lam AK
    Otolaryngol Head Neck Surg; 2023 May; 168(5):988-1005. PubMed ID: 36939466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.
    Liu X; Zhang Z; Zhang B; Zheng Y; Zheng C; Liu B; Zheng S; Dong K; Dong R
    EBioMedicine; 2018 Sep; 35():244-250. PubMed ID: 30104180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
    Punnoose EA; Atwal S; Liu W; Raja R; Fine BM; Hughes BG; Hicks RJ; Hampton GM; Amler LC; Pirzkall A; Lackner MR
    Clin Cancer Res; 2012 Apr; 18(8):2391-401. PubMed ID: 22492982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers.
    Merugu S; Chen L; Gavens E; Gabra H; Brougham M; Makin G; Ng A; Murphy D; Gabriel AS; Robinson ML; Wright JH; Burchill SA; Humphreys A; Bown N; Jamieson D; Tweddle DA
    Clin Cancer Res; 2020 Jan; 26(1):122-134. PubMed ID: 31767563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
    Radovich M; Jiang G; Hancock BA; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Shen F; Storniolo AMV; Badve S; Ballinger TJ; Chang CL; Zhong Y; Savran C; Miller KD; Schneider BP
    JAMA Oncol; 2020 Sep; 6(9):1410-1415. PubMed ID: 32644110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer.
    Gerratana L; Davis AA; Zhang Q; Basile D; Rossi G; Strickland K; Franzoni A; Allegri L; Mu Z; Zhang Y; Flaum LE; Damante G; Gradishar WJ; Platanias LC; Behdad A; Yang H; Puglisi F; Cristofanilli M
    JCO Precis Oncol; 2021 Jun; 5():943-952. PubMed ID: 34136741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Minimal Residual Disease in Neuroblastoma Patients.
    Uemura S; Ishida T; Thwin KKM; Yamamoto N; Tamura A; Kishimoto K; Hasegawa D; Kosaka Y; Nino N; Lin KS; Takafuji S; Mori T; Iijima K; Nishimura N
    Front Oncol; 2019; 9():455. PubMed ID: 31214500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
    Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
    Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor DNA in neuroblastoma.
    Wei M; Ye M; Dong K; Dong R
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28311. PubMed ID: 32729220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
    Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.